A Study to Assess the Clinical Effects of SCH 527123 in Psoriasis

Trial Profile

A Study to Assess the Clinical Effects of SCH 527123 in Psoriasis

Completed
Phase of Trial: Phase II

Latest Information Update: 15 May 2017

At a glance

  • Drugs Navarixin (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 01 Oct 2013 Planned number of patients changed from 30 to 31.
    • 11 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top